Azithromycin NDC 69306-250

NDC codes

FDA NDC Directory

Product NDC (as listed)69306-250Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69306-0250Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69306-250-06	69306025006	6 TABLET, FILM COATED in 1 BLISTER PACK (69306-250-06)Marketed from Apr 11, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Azithromycin
Generic name (nonproprietary): azithromycin
Active ingredients: Azithromycin dihydrate — 250 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Doc Rx
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210000
Marketing start: Mar 12, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Macrolides (Chemical structure)
Identifiers: Product ID 69306-250_c479da04-f3f7-fa5f-e053-2995a90a9ef8SPL ID c479da04-f3f7-fa5f-e053-2995a90a9ef8SPL set ID 90ff7cfc-73c9-4d77-83df-c05cfbbbbecdRxCUI 308460, 749783UNII 5FD1131I7SUPC 0369306250060
Pharmacologic class: Macrolide Antimicrobial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469306025006 followed by a unit qualifier and the quantity

Package 69306-0250-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 11, 2021.

Indications (excerpt from the label)

Azithromycin tablets are macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. Recommended dosages and durations of therapy in adult and pediatric patient populations vary in these indications. [see Dosage and Administration ( 2 )] Azithromycin is a macrolide antibacterial drug indicated for mild to moderate infections caused by designated, susceptible bacteria: Acute bacterial exacerbations of chronic bronchitis in adults ( 1.1 ) Acute bacterial sinusitis in adults ( 1.1 ) Uncomplicated skin and skin structure infections in adults ( 1.1 ) Ur…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 210000

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210000
Product	Strength	Form · route	Labeler	Product NDC
Azithromycin	Azithromycin dihydrate 250 mg/1	Tablet, Film coatedOral	DIRECT RX	72189-093
Azithromycin	Azithromycin dihydrate 250 mg/1	Tablet, Film coatedOral	Asclemed USA, Inc.	76420-649
Azithromycin	Azithromycin dihydrate 250 mg/1	Tablet, Film coatedOral	AvKARE	42291-082
Azithromycin	Azithromycin dihydrate 250 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-6436
Azithromycin	Azithromycin dihydrate 250 mg/1	Tablet, Film coatedOral	NuCare Pharmaceuticals,Inc.	68071-2266
Azithromycin	Azithromycin dihydrate 250 mg/1	Tablet, Film coatedOral	Proficient Rx LP	71205-424
Azithromycin	Azithromycin dihydrate 250 mg/1	Tablet, Film coatedOral	Bionpharma Inc.	69452-171